logo
Was Jim Cramer Right About The Walt Disney Company (DIS)?

Was Jim Cramer Right About The Walt Disney Company (DIS)?

Yahoo13 hours ago

We recently published a list of . In this article, we are going to take a look at where The Walt Disney Company (NYSE:DIS) stands against other stocks that Jim Cramer discusses.
In that episode, a caller admitted selling their shares of The Walt Disney Company (NYSE:DIS) to buy Nvidia. Cramer didn't criticize the move but defended Disney's long-term potential, noting that investor Nelson Peltz had also exited the stock. He explained:
'No one's catching a falling knife by buying Nvidia… Now we do know from my friend Scotty Wapner that Nelson Peltz is cleared out of Disney. I got to tell you, I'm in. I think he cleared out much higher. I have a big meeting tomorrow at 12:00 and I'm going to tell you why I think Disney is not something you should run away from. Not telling you to sell the Nvidia to get into Disney, but I don't care that Nelson's out — because I think that at these prices Nelson would probably join me in wanting to be in the situation.'
Good call by Cramer as the stock has recovered since and is now up +10.54%.
The Walt Disney Company (NYSE:DIS) is a diversified entertainment conglomerate with operations in film, television, streaming, theme parks, and consumer products globally.
Cramer remains a believer in Disney. Analyzing the stock's recent dip on May 15, he said the following:
'Look, these things occur every day around here. Think about what happened to the stock of Disney in the last few months… A month ago, it was at $82…. People were buzzing about how the theme parks are too expensive. The sports entertainment's too expensive. The movies are either too woke or not woke enough, depending on who you ask. You never heard anyone say, did it got the right amount? Now, one month later, Disney's at $112 pretty much in a straight line.
A packed theater of moviegoers watching a blockbuster film produced by the entertainment company.
Overall, DIS ranks 5th on our list of stocks that Jim Cramer discusses. While we acknowledge the potential of DIS as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. This article is originally published at Insider Monkey.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Here's How You Can Earn $100 In Passive Income By Investing In Air Products And Chemicals Stock
Here's How You Can Earn $100 In Passive Income By Investing In Air Products And Chemicals Stock

Yahoo

time44 minutes ago

  • Yahoo

Here's How You Can Earn $100 In Passive Income By Investing In Air Products And Chemicals Stock

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Air Products and Chemicals Inc. (NYSE:APD) provides atmospheric gases, process and specialty gases, equipment, and related services globally. The 52-week range of Air Products and Chemicals stock price was $243.69 to $341.14. Air Products and Chemicals' dividend yield is 2.57%. It paid $7.16 per share in dividends during the last 12 months. Don't Miss: Invest Where It Hurts — And Help Millions Heal: Maximize saving for your retirement and cut down on taxes: . On May 1, the company announced its Q2 2025 earnings, posting revenues of $2.92 billion, missing the consensus estimate of $2.93 billion, as reported by Benzinga. Adjusted EPS fell 6% year-over-year to $2.69, missing the $2.83 consensus, as lower volumes and higher costs were partly offset by strong pricing. The company expects Q3 adjusted EPS of $2.90 to $3, compared to the consensus of $3.28. For full-year 2025, the adjusted EPS is expected to be between $11.85 and $12.15, lowered from the prior range of $12.70 to $13, and missing the consensus of $12.55. Check out this article by Benzinga for nine analysts' insights on Air Products and Chemicals. Trending: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die." If you want to make $100 per month — $1,200 annually — from Air Products dividends, your investment value needs to be approximately $46,693, which is around 168 shares at $278.70 each. Understanding the dividend yield calculations: When making an estimate, you need two key variables — the desired annual income ($1,200) and the dividend yield (2.57% in this case). So, $1,200 / 0.0257 = $46,693 to generate an income of $100 per month. You can calculate the dividend yield by dividing the annual dividend payments by the current price of the stock. The dividend yield can change over time. This is the outcome of fluctuating stock prices and dividend payments on a rolling instance, assume a stock that pays $2 as an annual dividend is priced at $50. Its dividend yield would be $2/$50 = 4%. If the stock price rises to $60, the dividend yield drops to 3.33% ($2/$60). A drop in stock price to $40 will have an inverse effect and increase the dividend yield to 5% ($2/$40). In summary, income-focused investors may find Air Products stock an attractive option for making a steady income of $100 per month by owning 168 shares of stock. There may be more upside to come as investors benefit from the company's consistent dividend hikes. Air Products and Chemicals has raised its dividend consecutively for the last 43 years. Lower interest rates mean some investments won't yield what they did in months past, but you don't have to lose those gains. Certain private market real estate investments are giving retail investors the opportunity to capitalize on these high-yield opportunities. , which provides access to a pool of short-term loans backed by residential real estate. The best part? Unlike other private credit funds, Looking for fractional real estate investment opportunities? The features the latest offerings. Image: Shutterstock This article Here's How You Can Earn $100 In Passive Income By Investing In Air Products And Chemicals Stock originally appeared on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Bernstein Sticks to Its Buy Rating for Centene (CNC)
Bernstein Sticks to Its Buy Rating for Centene (CNC)

Business Insider

timean hour ago

  • Business Insider

Bernstein Sticks to Its Buy Rating for Centene (CNC)

Bernstein analyst Lance Wilkes maintained a Buy rating on Centene (CNC – Research Report) today and set a price target of $86.00. The company's shares closed today at $55.16. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Wilkes covers the Healthcare sector, focusing on stocks such as UnitedHealth, Humana, and Elevance Health. According to TipRanks, Wilkes has an average return of -0.3% and a 42.86% success rate on recommended stocks. In addition to Bernstein, Centene also received a Buy from Wells Fargo's Stephen Baxter in a report issued yesterday. However, on June 2, Barclays downgraded Centene (NYSE: CNC) to a Hold.

Molina Healthcare (MOH) Receives a Buy from Bernstein
Molina Healthcare (MOH) Receives a Buy from Bernstein

Business Insider

timean hour ago

  • Business Insider

Molina Healthcare (MOH) Receives a Buy from Bernstein

In a report released today, Lance Wilkes from Bernstein maintained a Buy rating on Molina Healthcare (MOH – Research Report), with a price target of $414.00. The company's shares closed today at $296.88. Confident Investing Starts Here: According to TipRanks, Wilkes is a 2-star analyst with an average return of -0.3% and a 42.86% success rate. Wilkes covers the Healthcare sector, focusing on stocks such as UnitedHealth, Humana, and Elevance Health. In addition to Bernstein, Molina Healthcare also received a Buy from Wells Fargo's Stephen Baxter in a report issued yesterday. However, on June 3, Barclays maintained a Hold rating on Molina Healthcare (NYSE: MOH). Based on Molina Healthcare's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $11.15 billion and a net profit of $298 million. In comparison, last year the company earned a revenue of $9.93 billion and had a net profit of $301 million Based on the recent corporate insider activity of 66 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of MOH in relation to earlier this year. Last month, Dale Wolf, a Director at MOH sold 1,500.00 shares for a total of $484,328.00.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store